Docetaxel (nanoparticle albumin-bound)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Docetaxel (nanoparticle albumin-bound), covering 2025-09-08 to 2025-09-08. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors [Phase 2]